spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  OVATION Pharmaceuticals 

 HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Feb 2011
Noven Appoints Lance D. Williams as Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2009
FDA Advisory Committee Unanimously Recommends Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Feb 2008
FDA Accepts for Review OVATION's Two NDA Submissions for Sabril(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Feb 2008
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Orphan Drug Designation Granted to OVATION's Clobazam for the Adjunctive Treatment of a Severe Form of Childhood Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Dec 2006
Phase II Data Shows Ovation's Novel Compound Clobazam to Be Well Tolerated in Patients With Catastrophic Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Sep 2006
OVATION and Cardinal Health Announce FDA Approval Letter for Manufacturing of Biologic Therapy To Treat Rare Genetic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jul 2006
OVATION Pharmaceuticals Announces First New Drug Treatment in 20 Years for Premature Infants with Patent Ductus Arteriosus
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
OVATION Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.